Watch CBS News

FDA gives full approval to a drug designed to slow Alzheimer's disease

Name: FDA gives full approval to a drug designed to slow Alzheimer's disease
Uploaded: 2023-07-06T18:30:00-0400
Duration: 2 min 14 s
Description: The Food and Drug Administration on Thursday gave its approval to Leqembi, a drug designed to slow the progression of Alzheimer's disease. Leqembi is not considered a cure for Alzheimer’s, but will be covered by Medicare. Dr. Jon LaPook has more.

The Food and Drug Administration on Thursday gave its approval to Leqembi, a drug designed to slow the progression of Alzheimer's disease. Leqembi is not considered a cure for Alzheimer’s, but will be covered by Medicare. Dr. Jon LaPook has more.